Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > BUSINESS
BUSINESS
- Meiji Scoops Up Marketing Rights for Mochida’s Epadel in Vietnam
April 7, 2020
- Fujifilm Wako to Launch Coronavirus Test on April 15
April 6, 2020
- Sumitomo Dainippon, Ehime Univ. Aim to Make New Malaria Vaccine IND-Ready by March 2022
April 6, 2020
- Big 3 Generic Maker Curbing Valsartan Shipments amid India Lockdown
April 6, 2020
- Japan Generic Market Crosses 1 Trillion Yen Mark in 2019: Fuji Keizai
April 6, 2020
- Denka to Resume Production of Compound for Avigan
April 3, 2020
- Alfresa Allies with Cell Therapy Startup; Possible Tripartite Collaboration with Rohto
April 3, 2020
- Takeda Launches Dedicated COVID-19 Website to Inform of Product Supply, R&D Status
April 3, 2020
- Eisai, Seikagaku Pair Up for Osteoarthritis Drug in China
April 2, 2020
- Amgen Kicks Off Stand-Alone Biz in Japan, Eyes Simultaneous Launch of Full Pipeline
April 2, 2020
- Pfizer Pausing Global Trial Recruitments, but Not in Japan
April 2, 2020
- Daiichi Sankyo Gets License to Ultragenyx’s Gene Therapy Manufacturing Techs
April 2, 2020
- Adcetris plus Chemo Gets EU Panel OK for Front-Line Use: Takeda
April 2, 2020
- Chugai Maps Out Digital Vision for 2030 Aiming at Value Chain Optimization, Novel Drug Discovery
April 2, 2020
- Takeda Introduces Claw-Back Policy for Executives Liable for Business Loss, Misconducts
April 2, 2020
- Post-Promotion Guidelines - 2: Takeda Evaluating “Non-Sales” Factors through Quality Conversations with Bosses
April 1, 2020
- Myovant Licenses European Rights for Relugolix Combo to Gedeon Richter
April 1, 2020
- SanBio Ties Up with China’s Ocumension for Stem Cell Therapies for Eyes
April 1, 2020
- Shionogi Files Xofluza for Post-Exposure Prophylaxis in Taiwan
April 1, 2020
- Fujifilm Launches Avigan Trial with Completion Eyed in June; Sanofi Too to Test Kevzara in Japan
April 1, 2020
